December 9, 2016
MSD President Jannie Oosthuizen MSD K.K., the Japan arm of Merck & Co., aims to roll out its immune checkpoint inhibitor Keytruda (pembrolizumab) early next year, President Jannie Oosthuizen said at a media reception on December 8, voicing his expectations...read more